We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer.AuthorsK. N. Chi; S. L. Ellard; S. J. Hotte; P. Czaykowski; M. Moore; J. D. Ruether; A. J. Schell; S. Taylor; C. Hansen; I. Gauthier; W. Walsh; L. SeymourPublicationAnnals of Oncology, 2008, Vol 19, Issue 4, p746ISSN0923-7534Publication typearticleDOI10.1093/annonc/mdm554